Obecetrapib, CETP inhibition, and atherosclerosis: there is light at the end of the tunnel

  • J Lipid Res. 2026 May;67(5):101029. doi: 10.1016/j.jlr.2026.101029.
Peter P Toth  1 ,  Maciej Banach  2
Affiliations
  • 1. Department of Preventive Cardiology, CGH Medical Center, Sterling, IL, USA; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: [email protected].
  • 2. Division of Cardiology, John Paul II Catholic University of Lublin (KUL), Lublin, Poland; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.
PMID: 41895605 DOI: 10.1016/j.jlr.2026.101029
Products